monoamine

(redirected from monoamine neurotransmitter)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

monoamine

[¦män·ō′am‚ēn]
(organic chemistry)
An amine compound that has only one amino group.
References in periodicals archive ?
Interactions between monoamine neurotransmitters system including 5-hydroxytryptamine (5-HT), noradrenaline (NA) and dopamine (DA) in the brain along with their specific reuptake and receptor protein has gain so much interest in the spectrum of antidepressant studies (Yi et al.
9) The monoamine hypothesis was developed following observation of antidepressant effects in drugs that increase synaptic concentrations of monoamine neurotransmitters.
Despite these drawbacks, CSF monoamine neurotransmitter metabolite analysis has become fairly routine in many research laboratories and in specialized clinical laboratories that search for changes that might indicate problems in this area of neurochemistry.
Although current theories recognize that depleted monoamine neurotransmitters may be involved in the pathogenesis of depression, they also acknowledge that other factors may be involved.
5-HT is a monoamine neurotransmitter in the mammalian CNS, where it plays an important role in regulating mood, memory and many other functions.
Beta-PEA is a monoamine neurotransmitter that has amphetamine-like functions that can alter mood and attention, and decreased beta-PEA levels may contribute to symptoms of inattentiveness (Berry 2004).
Although their mechanisms of action are not fully understood, MAOIs, including EMSAM, are presumed to work through potentiation of monoamine neurotransmitter activity in the brain by inhibiting the MAO enzyme.
Older schizophrenia patients may clinically remit because of normal reductions of dopaminergic, noradrenergic, and serotonergic activity that are associated with aging; many researchers think that some of the symptoms of schizophrenia, especially positive symptoms, are caused by increased monoamine neurotransmitter activity.
In summary, the present study confirmed the antidepressant-like effects of SCLPN in the FST and CMS model and demonstrated that SCLPN may exert these effects through a monoamine neurotransmitter mechanism.
Effect of TFY on monoamine neurotransmitter in brain of nitroglycerin-induced migraine rats